These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8264949)

  • 1. Prion protein is strongly immunolocalized at the postsynaptic domain of human normal neuromuscular junctions.
    Askanas V; Bilak M; Engel WK; Leclerc A; Tomé F
    Neurosci Lett; 1993 Sep; 159(1-2):111-4. PubMed ID: 8264949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strong immunoreactivity of beta-amyloid precursor protein, including the beta-amyloid protein sequence, at human neuromuscular junctions.
    Askanas V; Engel WK; Alvarez RB
    Neurosci Lett; 1992 Aug; 143(1-2):96-100. PubMed ID: 1436686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha 1-antichymotrypsin is strongly immunolocalized at normal human and rat neuromuscular junctions.
    Bilak M; Askanas V; Engel WK
    Synapse; 1994 Apr; 16(4):280-3. PubMed ID: 8059338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunocytochemical localization of ubiquitin at human neuromuscular junctions.
    Serdaroglu P; Askanas V; Engel WK
    Neuropathol Appl Neurobiol; 1992 Jun; 18(3):232-6. PubMed ID: 1321352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunocytochemical localization of desmin at human neuromuscular junctions.
    Askanas V; Bornemann A; Engel WK
    Neurology; 1990 Jun; 40(6):949-53. PubMed ID: 2189082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strong immunoreactivity of platelet-derived growth factor and its receptor at human and mouse neuromuscular junctions.
    Zhao Y; Haginoya K; Iinuma K
    Tohoku J Exp Med; 1999 Dec; 189(4):239-44. PubMed ID: 10739160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ultrastructural localization and quantitation of cholinergic receptors at the mouse motor endplate.
    Porter CW; Barnard EA; Chiu TH
    J Membr Biol; 1973; 14(4):383-402. PubMed ID: 4781450
    [No Abstract]   [Full Text] [Related]  

  • 8. Is dystrophin present in the nerve terminal at the neuromuscular junction? An immunohistochemical study of the heterozygote dystrophic (mdx) mouse.
    Huard J; Fortier LP; Labrecque C; Dansereau G; Tremblay JP
    Synapse; 1991 Feb; 7(2):135-40. PubMed ID: 2011828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunolocalization of nitric oxide synthases at the postsynaptic domain of human and rat neuromuscular junctions--light and electron microscopic studies.
    Yang CC; Alvarez RB; Engel WK; Haun CK; Askanas V
    Exp Neurol; 1997 Nov; 148(1):34-44. PubMed ID: 9398448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A light and electron microscopic study of dystrophin localization at the mouse neuromuscular junction.
    Huard J; Fortier LP; Dansereau G; Labrecque C; Tremblay JP
    Synapse; 1992 Feb; 10(2):83-93. PubMed ID: 1585259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 300-kD subsynaptic protein copurifies with acetylcholine receptor-rich membranes and is concentrated at neuromuscular synapses.
    Woodruff ML; Theriot J; Burden SJ
    J Cell Biol; 1987 Apr; 104(4):939-46. PubMed ID: 3558487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fate of alpha-bungarotoxin bound to acetylcholine receptors of normal and denervated muscle.
    Berg DK; Hall ZW
    Science; 1974 Apr; 184(4135):473-5. PubMed ID: 4819679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different distributions of dystrophin and related proteins at nerve-muscle junctions.
    Bewick GS; Nicholson LV; Young C; O'Donnell E; Slater CR
    Neuroreport; 1992 Oct; 3(10):857-60. PubMed ID: 1421088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of neuromuscular junctions in striated muscle of human esophagus demonstrated by triple staining for the vesicular acetylcholine transporter, alpha-bungarotoxin, and acetylcholinesterase.
    Kallmünzer B; Sörensen B; Neuhuber WL; Wörl J
    Cell Tissue Res; 2006 May; 324(2):181-8. PubMed ID: 16437206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defects in neuromuscular junction structure in dystrophic muscle are corrected by expression of a NOS transgene in dystrophin-deficient muscles, but not in muscles lacking alpha- and beta1-syntrophins.
    Shiao T; Fond A; Deng B; Wehling-Henricks M; Adams ME; Froehner SC; Tidball JG
    Hum Mol Genet; 2004 Sep; 13(17):1873-84. PubMed ID: 15238508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prion protein is abnormally accumulated in inclusion-body myositis.
    Askanas V; Bilak M; Engel WK; Alvarez RB; Tomé F; Leclerc A
    Neuroreport; 1993 Oct; 5(1):25-8. PubMed ID: 8280854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatial relationships of utrophin, dystrophin, beta-dystroglycan and beta-spectrin to acetylcholine receptor clusters during postnatal maturation of the rat neuromuscular junction.
    Bewick GS; Young C; Slater CR
    J Neurocytol; 1996 Jul; 25(7):367-79. PubMed ID: 8866238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuromuscular junctions contain NP185: the multifunctional protein is located at the presynaptic site.
    Perry DG; Li S; Hanson V; Puszkin S
    J Neurosci Res; 1992 Nov; 33(3):408-17. PubMed ID: 1469744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo imaging shows loss of synaptic sites from neuromuscular junctions in a model of myasthenia gravis.
    Rich MM; Colman H; Lichtman JW
    Neurology; 1994 Nov; 44(11):2138-45. PubMed ID: 7969973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetylcholine receptor aggregation parallels the deposition of a basal lamina proteoglycan during development of the neuromuscular junction.
    Anderson MJ; Klier FG; Tanguay KE
    J Cell Biol; 1984 Nov; 99(5):1769-84. PubMed ID: 6386827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.